Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Seagate Technology Holdings PLC (STX) Price & Performance

Enveric Biosciences IncTrade
Seagate Technology Holdings PLCTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Seagate Technology Holdings PLC — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Seagate Technology Holdings PLC trades at $753.6 (market cap $187.40B). The key difference: Seagate Technology Holdings PLC is far larger — about 35225.6× Enveric Biosciences Inc's market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBSTX
Market Cap
$5.32M$187.40B
Sector
HealthTechnology
52-Week High
$17.40$1.09K
52-Week Low
$1.28$146.59
Enterprise Value
$408.82K$190.44B
Dividend Yield
0.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.

Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.

Seagate Technology Holdings PLC

Seagate Technology (STX) trades at $878.31, up 2.05% with strong recent earnings beats and bullish analyst sentiment. The stock shows robust fundamentals with 21.6% net margins and 96.27% ROE, though valuation metrics appear elevated with P/E at 78.59. Technical indicators are neutral overall with support at $866 and resistance at $893, while the company benefits from AI-driven storage demand and positive industry outlook.

Outlook remains positive with 54.9% analyst buy ratings and $987.86 consensus target, representing 12.5% upside. Key risks include high debt levels (73.31% debt-to-asset ratio) and competitive pressures in the memory sector. The upcoming Q2 earnings report on July 28, 2026, with expected EPS of $5.10, will be critical for near-term direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Seagate Technology Holdings PLC

Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital

Read more on STX